Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04453059 · ClinicalTrials.gov registry record
Study With Oral Isovue in Abdominopelvic CT
A clinical trial, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- 218
- Enrollment target
NCT04453059: Completed study, sponsored by Bracco Diagnostics.
NCT04453059 is a clinical trial that has completed, run by Bracco Diagnostics. The registered enrollment target is 218 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04453059 has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- 218 participants
- Enrollment target
Study Summary
This is a retrospective clinical study with prospectively designed blinded evaluation of CT images in adult and pediatric patients who underwent CT examinations of the abdomen and pelvis and were orally administered a solution of Isovue-300 to opacify the GI tract to distinguish it from adjacent abdominal and pelvic structures. The study will collect already existing data, such as demographic data, adverse events and CT images, for all chronologically enrolled patients who meet the inclusion/exclusion criteria prospectively defined in this protocol
Interventions
- DRUG Iopamidol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2022-07-01 |
What the finished NCT04453059 record still lists
NCT04453059 is an observational study that tracks outcomes without assigning an intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Iopamidol is the first listed.
NCT04453059 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04453059 about?
NCT04453059 is a clinical study titled "Study With Oral Isovue in Abdominopelvic CT". This is a retrospective clinical study with prospectively designed blinded evaluation of CT images in adult and pediatric patients who underwent CT examinations of the abdomen and pelvis and were orally administered a solution of Isovue-300 to opacify the GI tract to distinguish it from adjacent abd...
What is the current status of trial NCT04453059?
This trial is currently completed. The enrollment target is 218 participants. The study started on 2021-07-01. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04453059?
The interventions under investigation include: Iopamidol (DRUG).
Who is sponsoring clinical trial NCT04453059?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI